-
1دورية أكاديمية
المؤلفون: Valsalakumari R, Pandya AD, Prasmickaite L, Kvalvaag A, Myrann AG, Åslund AKO, Kjos MS, Fontecha-Cuenca C, Haroon HB, Ribeiro ARS, Horejs-Hoeck J, Moghimi SM, Mørch Ý, Skotland T, Sandvig K, Mælandsmo GM, Iversen TG
المصدر: International Journal of Nanomedicine, Vol Volume 19, Pp 3009-3029 (2024)
مصطلحات موضوعية: poly(alkyl cyanoacrylate), cabazitaxel, breast cancer, patient derived xenograft, tumor microenvironment, Medicine (General), R5-920
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Haugen, MH, Gythfeldt, HV, Egeland, EV, Normann, LS, Pandya, AD, Vedin, LL, Juell, S, Tenstad, E, Oy, GF, Kristian, A, Marangoni, E, Sorlie, T, Steffensen, K, Maelandsmo, GM, Engebraaten, O
المصدر: Molecular oncology. 17(10):2041-2055
مصطلحات موضوعية: Medicin och hälsovetenskap
-
3دورية أكاديمية
المؤلفون: Pandya AD, Jäger E, Bagheri Fam S, Höcherl A, Jäger A, Sincari V, Nyström B, Štěpánek P, Skotland T, Sandvig K, Hrubý M, Mælandsmo GM
المصدر: International Journal of Nanomedicine, Vol Volume 14, Pp 6269-6285 (2019)
مصطلحات موضوعية: Reactive oxygen species, ROS-sensitive nanoparticles, Paclitaxel, Treatment efficacy, Macrophage infiltration, Medicine (General), R5-920
وصف الملف: electronic resource
-
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8
المؤلفون: Fusser M; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Øverbye A; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Pandya AD; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Mørch Ý; Department of Biotechnology and Nanomedicine, SINTEF, AS, Trondheim, Norway., Borgos SE; Department of Biotechnology and Nanomedicine, SINTEF, AS, Trondheim, Norway., Kildal W; Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Snipstad S; Department of Biotechnology and Nanomedicine, SINTEF, AS, Trondheim, Norway; Department of Physics, The Norwegian University of Science and Technology, Trondheim, Norway., Sulheim E; Department of Biotechnology and Nanomedicine, SINTEF, AS, Trondheim, Norway; Department of Physics, The Norwegian University of Science and Technology, Trondheim, Norway., Fleten KG; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Askautrud HA; Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Engebraaten O; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; Institute for Clinical Medicine, The Medical Faculty, University of Oslo, Oslo, Norway., Flatmark K; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; Institute for Clinical Medicine, The Medical Faculty, University of Oslo, Oslo, Norway., Iversen TG; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Sandvig K; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; Department of Biosciences, University of Oslo, Oslo, Norway., Skotland T; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. Electronic address: torsko@rr-research.no., Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; Department of Pharmacy, University of Tromsø, Tromsø, Norway.
المصدر: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2022 Sep; Vol. 349, pp. 1. Date of Electronic Publication: 2022 Jul 02.
نوع المنشور: Published Erratum
بيانات الدورية: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: PubMed not MEDLINE; MEDLINE
-
9دورية أكاديمية
المؤلفون: Pandya AD; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, 0379 Oslo, Norway., Iversen TG; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, 0379 Oslo, Norway., Moestue S; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway., Grinde MT; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, 7491 Trondheim, Norway., Mørch Ý; SINTEF AS, Department of Biotechnology and Nanomedicine, 7034 Trondheim, Norway., Snipstad S; SINTEF AS, Department of Biotechnology and Nanomedicine, 7034 Trondheim, Norway.; Department of Physics, Norwegian University of Science and Technology, 7491 Trondheim, Norway.; Cancer Clinic, St. Olav's Hospital, 7030 Trondheim, Norway., Åslund AKO; SINTEF AS, Department of Biotechnology and Nanomedicine, 7034 Trondheim, Norway., Øy GF; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, 0379 Oslo, Norway., Kildal W; Institute for Cancer Genetics and Informatics, Oslo University Hospital, The Norwegian Radium Hospital, 0379 Oslo, Norway., Engebråten O; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, 0379 Oslo, Norway.; Department of Oncology, Oslo University Hospital, 0450 Oslo, Norway.; Institute of Clinical Medicine, Medical Faculty, University of Oslo, 0315 Oslo, Norway., Sandvig K; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, 0379 Oslo, Norway.; Department of Biosciences, University of Oslo, 0315 Oslo, Norway., Skotland T; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, 0379 Oslo, Norway., Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, 0379 Oslo, Norway.; Department of Medical Biology, University of Tromsø, 9019 Tromsø, Norway.
المصدر: Nanomaterials (Basel, Switzerland) [Nanomaterials (Basel)] 2021 Apr 28; Vol. 11 (5). Date of Electronic Publication: 2021 Apr 28.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101610216 Publication Model: Electronic Cited Medium: Print ISSN: 2079-4991 (Print) Linking ISSN: 20794991 NLM ISO Abbreviation: Nanomaterials (Basel) Subsets: PubMed not MEDLINE
-
10دورية أكاديمية
المؤلفون: Valsalakumari R; Department of Biomedical Engineering, Indian Institute of Technology, Hyderabad, India., Yadava SK; Department of Biomedical Engineering, Indian Institute of Technology, Hyderabad, India., Szwed M; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway; Department of Medical Biophysics, Institute of Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland., Pandya AD; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway; Institute of Medical Biology, The Arctic University of Norway, University of Tromsø, Tromsø, Norway., Torgersen ML; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Iversen TG; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Skotland T; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Sandvig K; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway; Department of Biosciences, University of Oslo, Oslo, Norway. Electronic address: ksandvig@radium.uio.no., Giri J; Department of Biomedical Engineering, Indian Institute of Technology, Hyderabad, India. Electronic address: jgiri@bme.iith.ac.in.
المصدر: International journal of pharmaceutics [Int J Pharm] 2021 Mar 15; Vol. 597, pp. 120217. Date of Electronic Publication: 2021 Jan 21.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE
مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Nanocapsules*, Animals ; Cell Line, Tumor ; Female ; Humans ; Lipids ; Mice ; Paclitaxel ; Tissue Distribution